Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells
The development of biomimetic hybrid liposomes represents a promising approach for the treatment of glioblastoma. By combining the advantages of liposomal drug delivery with the stealth properties and targeting capabilities of cell membrane fragments, these nanoparticles can potentially overcome the challenges associated with traditional therapies.
Authors
- Angela Lopedota (ORCID: https://orcid.org/0000-0003-4283-7063)
- Rosa Maria Iacobazzi (ORCID: https://orcid.org/0000-0002-0737-6591)
- Raquel Bártolo (ORCID: https://orcid.org/0000-0002-5002-4225)
- Letizia Porcelli (ORCID: https://orcid.org/0000-0003-0175-9716)
- R. Fonte (ORCID: https://orcid.org/0000-0002-8541-686X)
- Amalia Azzariti (ORCID: https://orcid.org/0000-0002-6149-5049)
- Ilaria Arduino (ORCID: https://orcid.org/0000-0001-6881-7461)
- Hélder A. Santos (ORCID: https://orcid.org/0000-0001-7850-6309)
- Federica Sommonte (ORCID: https://orcid.org/0000-0001-8227-2939)
- Simona Serratì (ORCID: https://orcid.org/0000-0002-4015-5205)
- Nunzio Denora (ORCID: https://orcid.org/0000-0002-7756-7828)
- Jiachen Li (ORCID: https://orcid.org/0000-0001-8311-4043)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Istituto Tumori Bari (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ijn.s489872
- Citations
- 9
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Ministero della Salute
- Universita degli Studi di Bari Aldo Moro